EUVIMEDEUVIMED entdecken
Crossref

High‐Sensitivity LC–MS/MS Method for Simultaneous Determination of Structurally Related Impurities 2‐Isoniazid, 3‐Isoniazid and Isonicotinamide in Isoniazid Active Pharmaceutical Ingredient

Rajesh Kumar Boggavarapu iD, Venkateswara Rao Yamarthi iD, Jithendra Chimakurthy iD

Journal of Mass Spectrometry · 2026-11 · 61 (11)

DOI: 10.1002/jms.70124 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Mass Spectrometry, online erschienen am 19.10.2026. Verfasst von Rajesh Kumar Boggavarapu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Vignan's Foundation for Science, Technology and Research, Guntur, Andhra Pradesh, India. Hauptthemen laut MEDLINE: Isoniazid, Tandem Mass Spectrometry, Drug Contamination, Liquid Chromatography-Mass Spectrometry. Die Arbeit nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A sensitive, selective and rapid liquid chromatography–tandem mass spectrometry (LC–MS/MS) method was developed and validated for the simultaneous quantification of trace impurities, namely, 2‐isoniazid, 3‐isoniazid and isonicotinamide, in isoniazid active pharmaceutical ingredient (API) at parts‐per‐million (ppm) levels. Chromatographic separation was achieved within 6 min using a Zorbax SB Aq column maintained at 40°C. The mobile phase consisted of 10 mM ammonium formate buffer (pH 4.0, adjusted with formic acid) and 0.1% (v/v) formic acid in acetonitrile (48:52, v/v), delivered at a flow rate of 1.0 mL/min. The optimized conditions provided efficient separation, reproducible peak responses and stable ionization for all analytes. The method was validated in accordance with ICH Q2 guidelines with respect to specificity, accuracy, precision, linearity, range, detection limit and quantitation limit. The limits of detection and quantification were established at 0.8 and 2.5 ppm, respectively, demonstrating the high sensitivity of the method for trace impurity determination. The validated method was successfully applied to the analysis of isoniazid bulk drug samples and enabled consistent and accurate quantification of the impurities. The developed LC–MS/MS method is rapid, robust and suitable for routine quality control testing and regulatory impurity monitoring of isoniazid API.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IsoniazidTandem Mass SpectrometryDrug ContaminationLiquid Chromatography-Mass SpectrometryAntitubercular AgentsBulk DrugsReproducibility of ResultsSensitivity and SpecificityLimit of DetectionChromatography, LiquidNiacinamide

Stichwörter der Autor:innen

LC–MS/MSchromatographic separationimpurity profilingisoniazid APImethod validation (ICH Q2(R1))parts per millionpharmaceutical analysispharmaceutical analytical method developmenttrace‐level quantification

Substanzen

IsoniazidBulk DrugsisonicotinamideAntitubercular AgentsNiacinamide

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, Vignan's Foundation for Science, Technology and Research, Guntur, Andhra Pradesh, India.

ORCID-Profile: Rajesh Kumar Boggavarapu, Venkateswara Rao Yamarthi, Jithendra Chimakurthy

Zitieren

APA

Boggavarapu, R. K., Yamarthi, V. R., & Chimakurthy, J. (2026). High‐Sensitivity LC–MS/MS Method for Simultaneous Determination of Structurally Related Impurities 2‐Isoniazid, 3‐Isoniazid and Isonicotinamide in Isoniazid Active Pharmaceutical Ingredient. Journal of Mass Spectrometry, 61(11). https://doi.org/10.1002/jms.70124

Vancouver

Boggavarapu RK, Yamarthi VR, Chimakurthy J. High‐Sensitivity LC–MS/MS Method for Simultaneous Determination of Structurally Related Impurities 2‐Isoniazid, 3‐Isoniazid and Isonicotinamide in Isoniazid Active Pharmaceutical Ingredient. Journal of Mass Spectrometry. 2026;61(11). doi:10.1002/jms.70124

BibTeX
@article{Boggavarapu2026,
  author = {Boggavarapu, Rajesh Kumar and Yamarthi, Venkateswara Rao and Chimakurthy, Jithendra},
  title = {High‐Sensitivity LC–MS/MS Method for Simultaneous Determination of Structurally Related Impurities 2‐Isoniazid, 3‐Isoniazid and Isonicotinamide in Isoniazid Active Pharmaceutical Ingredient},
  journal = {Journal of Mass Spectrometry},
  year = {2026},
  volume = {61},
  number = {11},
  doi = {10.1002/jms.70124}
}
Kostenlos starten →